Bruker completed the acquisition of Dynamic Biosensors.

Bruker, an American manufacturer of scientific instruments for molecular and materials research, completed the acquisition of Dynamic Biosensors, a provider of molecular interaction cytometry solutions. Financial terms were not disclosed. "This strategic acquisition enhances Bruker’s position in the pharma and biotech industries by combining the cutting-edge Dynamic Biosensors instruments and Bruker’s leading high-throughput SPR portfolio, establishing a new technology leader in biosensors with a differentiated offering," Meike Hamester, Bruker Biosensors Vice President.